Home Eton Pharmaceuticals

Eton Pharmaceuticals

acquired
IPO
Developer of Rare Disease Treatment Products

Basic Information

Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company offers: Biorphen®, an injectable phenylephrine solution used to treat clinically significant hypotension primarily caused by vasodilation in anesthesia settings; Alkindi Sprinkle®, a replacement therapy for adrenal insufficiency in children under 17; Carglumic Acid, the only FDA-approved generic bioequivalent and therapeutic equivalent to Carbaglu® (carglumic acid); and Alaway® Preservative Free, a preservative-free ophthalmic product for treating allergic conjunctivitis.
Eton Pharmaceuticals, Inc.
Illinois,United States of America
15~50 people
January 01, 2017
info@etonpharmaceuticals.com